Magnolia Medical Technologies

Magnolia Medical Technologies is a healthcare solutions company dedicated to improving diagnostic accuracy and patient outcomes. They develop advanced products like the Steripath Initial Specimen Diversion Device, which is FDA-cleared to reduce blood culture contamination and enhance sepsis testing accuracy. Magnolia Medical aims to eliminate sepsis misdiagnosis, reduce unnecessary antibiotic use, and improve the quality and cost-effectiveness of healthcare. Their mission is to set new standards in diagnostic stewardship, driving better clinical decisions through evidence-backed solutions.